£2m study aims to improve early stage ovarian cancer diagnosis
A £2 million study will see an advanced test used at GP surgeries in the West Midlands to diagnose early-stage ovarian cancer – potentially saving thousands of lives a year.The project involves BHP m…
UHB launches mRNA cancer vaccine trial for colorectal cancer
BHP founder-members University Hospitals Birmingham NHS Foundation Trust (UHB) has become the UK’s first site to launch the BioNTech Messenger RNA (mRNA) cancer vaccines trial which aims to recruit 1…
Incurable blood cancer trial finds new drug better than current treatments
Patients with an incurable blood cancer – polycythaemia vera (PV) – may respond better to a new drug compared to conventional best treatment, a new clinical trial has found.
The rare cancer result…
Second city’s strategic health alliance welcomes mental health trust as new member
Birmingham Health Partners has underlined its commitment to delivering research that enhances health and wellbeing by welcoming Birmingham and Solihull Mental Health NHS Foundation Trust (BSMHFT) as…
‘Vein-on-a-chip’ could help scientists study blood clots without animal models
Blood clot researchers could benefit from a new device that mimics a human vein, replacing the need for animals for some studies.
The vein-on-a-chip model has been developed by scientists at BHP f…
Drug combination could overcome tumour resistance in paediatric cancers
Children with some solid tumours may benefit from receiving a combination of inhibitor drugs, according to interim results of research presented at the American Association of Cancer Research’s Annua…